Diagnostic Tests: Sucrose Lysis Test

Overview — What This Test Is

The sucrose lysis test is a screening test for paroxysmal nocturnal hemoglobinuria (PNH).
In this test, the patient’s red blood cells are placed in a sucrose-containing solution, which promotes complement activation. PNH RBCs are unusually sensitive to complement-mediated destruction, so the presence of hemolysis in this solution suggests PNH.

The mechanism:

• PNH cells lack protective surface proteins (CD55, CD59) that normally prevent complement-mediated lysis.
• Sucrose enhances complement binding → RBC destruction → hemolysis detected.

When to Answer “Sucrose Lysis Test”

Choose the sucrose lysis test in a clinical scenario that describes the classic features of PNH, such as:

• Dark urine in the morning (from overnight hemoglobinuria)
• Episodic hemolysis
• Pancytopenia
• Venous thrombosis, especially in unusual sites such as hepatic, portal, or cerebral veins
• Negative Coombs test (helps distinguish PNH from autoimmune hemolysis)

When these features appear together, the sucrose lysis test is the classic screening test.

Most Accurate Diagnostic Test

The most accurate and modern diagnostic test for PNH is:

Flow Cytometry for CD55 and CD59 Deficiency

• These proteins are also called decay-accelerating factor (DAF) and membrane inhibitor of reactive lysis (MIRL).
• PNH cells are missing CD55 and CD59 due to a mutation in the PIGA gene affecting the GPI anchor that normally attaches these protective proteins to the cell surface.

Flow cytometry is the gold standard because it directly demonstrates the absence of these protective markers on RBCs and WBCs.

Diagnostic Tests: Peripheral Smear Findings in G6PD Deficiency

Overview — What the Peripheral Smear Shows

This peripheral smear demonstrates Heinz bodies, which are inclusions formed by precipitated, oxidized hemoglobin inside red blood cells. These occur when RBCs are exposed to oxidative stress in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
G6PD deficiency is an X-linked recessive condition and is particularly common in African-American males (10–15%).


Clinical Scenario — When This Is the Correct Answer

You should suspect G6PD deficiency when the presentation describes a previously healthy male who suddenly develops signs of acute intravascular hemolysis after oxidative stress. Key features include:

• Weakness and fatigue
• Tachycardia
• Jaundice
• Dark urine (hemoglobinuria)
• Sudden drop in hemoglobin

Common triggers of oxidative stress include:

• Infections (most common cause)
• Drugs, including:
  • Sulfa drugs
  • Primaquine
  • Dapsone
  • Quinidine
  • Nitrofurantoin


• Fava beans (favism)

When a question stem includes these triggers plus acute hemolysis and the smear shows characteristic RBC inclusions, G6PD deficiency is the diagnosis.

Other Cells Characteristic of G6PD Deficiency

Once Heinz bodies form, the spleen attempts to remove them. This “pitting” process produces:

Bite cells (degmacytes)

• RBCs appear as though a bite has been taken out of them.
• These cells are classic for G6PD deficiency and often accompany Heinz body formation.

Definitive Diagnostic Test

The definitive test for confirming G6PD deficiency is:

Measurement of G6PD enzyme level

Important caveat:
You must wait approximately 2 months after the hemolytic episode to test.
Immediately after hemolysis, the older, most deficient red cells have already been destroyed. The remaining population consists of young reticulocytes with relatively higher G6PD activity, which can give a false-normal result.


If you’d like, I can also create a comparison chart of G6PD deficiency vs. other hemolytic anemias (like autoimmune hemolysis or sickle cell), or provide a rapid-review summary for exams.

Diagnostic Tests: Hairy Cell Leukemia (Blood Smear Findings)


Overview — What the Blood Smear Shows

The blood smear displays lymphoid cells with characteristic cytoplasmic projections, known as “hairy cells.” These projections give the cells a fuzzy or “hairy” appearance, which is the classic morphologic hallmark of hairy cell leukemia (HCL). This is a rare, chronic B-cell lymphoproliferative disorder.


Clinical Scenario — When to Suspect and Answer Hairy Cell Leukemia

Hairy cell leukemia should be strongly suspected when the clinical presentation includes:

• A middle-aged man (most common demographic)
• Gradual onset of fatigue, weakness, or recurrent infections
• Massive splenomegaly, often the dominant physical finding
• Hepatomegaly (present in about 50% of patients)
• Pancytopenia, which is the hallmark laboratory abnormality
  • Particularly monocytopenia
  • Bone marrow often becomes fibrotic and difficult to aspirate (“dry tap”)

This combination—middle-aged patient, massive splenomegaly, pancytopenia, and characteristic smear findings—points to hairy cell leukemia.


Most Accurate Diagnostic Test


The most accurate test for confirming hairy cell leukemia is:

Tartrate-Resistant Acid Phosphatase (TRAP) positivity

• Performed on a bone marrow biopsy
• Hairy cells show strong acid phosphatase activity that remains positive even in the presence of tartrate, distinguishing them from other leukemic cells.

(Modern practice also uses flow cytometry markers such as CD11c, CD25, CD103, and detection of BRAF V600E mutation, but TRAP is the classic board-test answer.)


If you’d like, I can also create a rapid diagnostic table comparing hairy cell leukemia with CLL, AML, and other pancytopenia causes.

Clinical Scenario — When to Suspect and Answer Hairy Cell Leukemia

Hairy cell leukemia should be strongly suspected when the clinical presentation includes:

• A middle-aged man (most common demographic)
• Gradual onset of fatigue, weakness, or recurrent infections
• Massive splenomegaly, often the dominant physical finding
• Hepatomegaly (present in about 50% of patients)
• Pancytopenia, which is the hallmark laboratory abnormality
  • Particularly monocytopenia
  • Bone marrow often becomes fibrotic and difficult to aspirate (“dry tap”)

This combination—middle-aged patient, massive splenomegaly, pancytopenia, and characteristic smear findings—points to hairy cell leukemia.

Diagnostics Tests: Hypersegmented Neutrophils

Overview

A hypersegmented neutrophil is a neutrophil with an abnormally high number of nuclear lobes. Normal neutrophils average about 3–4 lobes, but when the average exceeds 4 lobes, or when 5% of cells have ≥5 lobes, or when even a single 6-lobed neutrophil is present, the finding is considered hypersegmentation. This morphological change is a classic hematologic clue and serves as a defining feature of megaloblastic anemia.


Associated Diseases

Hypersegmented neutrophils are most commonly seen in:

• Vitamin B12 deficiency
• Folate deficiency

These deficiencies impair DNA synthesis, leading to delayed nuclear maturation in hematopoietic cells. The result is macrocytosis, ineffective erythropoiesis, and the hallmark hypersegmented neutrophils seen on peripheral blood smear. These findings may accompany clinical features like glossitis, anemia, and—in B12 deficiency—neurologic symptoms.


Most Accurate Diagnostic Tests

To confirm megaloblastic anemia and determine its cause, the following tests are most accurate:

• Serum vitamin B12 and folate levels – first-line and most direct assessment.
• Methylmalonic acid (MMA) – elevated in B12 deficiency only, not folate deficiency, making it helpful for distinguishing between the two.
• Homocysteine levels – elevated in both B12 and folate deficiency (helps support the diagnosis, but not specific).
• Anti–intrinsic factor antibodies and antiparietal cell antibodies – used to identify pernicious anemia, the classic autoimmune cause of B12 deficiency.

Therapy

Treatment depends on the underlying deficiency:

• Vitamin B12 deficiency:
  • Replacement with intramuscular B12 injections for severe deficiency or malabsorption
  • Oral B12 for mild cases or dietary deficiency
  • Lifelong therapy is required for pernicious anemia
• Folate deficiency:
  • Oral folic acid supplementation
  • Dietary improvement
  • Important note: Never treat with folate alone if B12 deficiency is possible, as folate can correct the anemia while allowing neurologic damage from B12 deficiency to persist or worsen.

Diagnostic Tests-Tests: D-Dimer and Fibrin Split Products
Overview

D-dimer and fibrin split products (FSPs) are laboratory markers that reflect activation of the coagulation and fibrinolytic systems. D-dimer is generated when plasmin degrades cross-linked fibrin, whereas fibrin split products are formed when thrombin acts on fibrinogen, producing degradation fragments. Both markers become clinically significant when elevated, as they indicate abnormal or excessive clot formation and breakdown within the body.

Measurement Methods


D-dimer levels can be measured through two commonly used laboratory techniques:

• Latex agglutination assay:
  A rapid test, useful for quick screening but less sensitive.
• ELISA (enzyme-linked immunosorbent assay):
  The most accurate and far more sensitive method, capable of detecting very low levels of D-dimer. Because of its high sensitivity, the ELISA is the preferred test when ruling out thrombotic conditions such as deep vein thrombosis (DVT) or pulmonary embolism (PE).

Fibrin split products are measured through similar immunologic methods, but they are primarily ordered in the evaluation of disseminated intravascular coagulation (DIC).

What These Tests Detect

Elevated D-dimer and FSP levels indicate pathologic clot formation and subsequent fibrinolysis. When the coagulation cascade is activated, fibrin clots form and are later broken down, generating measurable fragments.
Importantly, these tests do not assess platelet function and provide no information about platelet aggregation or adhesion disorders.

Interpretation of Test Results

• Elevated levels suggest active clot formation and breakdown and are characteristic of conditions such as:
  • Disseminated intravascular coagulation (DIC)
  • Recent surgery or trauma
  • Infection or sepsis
  • Malignancy
  • Venous thromboembolism (DVT or PE)


• A negative ELISA D-dimer is powerful for ruling out DVT or PE in patients with a low pretest probability.
• However, a positive D-dimer is not diagnostic of DVT or PE because many conditions can elevate it.
• In DIC, both D-dimer and fibrin split products are elevated, reflecting uncontrolled coagulation and fibrinolysis.

When to Order These Tests

D-dimer and fibrin split products should be ordered in the following scenarios:

• To evaluate suspected DIC, particularly when accompanied by thrombocytopenia, prolonged PT/aPTT, and clinical evidence of bleeding or thrombosis.
• To rule out pulmonary embolism or deep vein thrombosis, but only in patients with low pretest probability, where a negative ELISA D-dimer effectively excludes the diagnosis.
• As supportive evidence in conditions involving widespread clot formation and fibrinolysis.

Diagnostic Tests: Target Cells

Overview — What These Are?

The cells shown are target cells (codocytes). Target cells have a characteristic “bull’s-eye” appearance caused by an excess of cell membrane relative to cell volume. This altered surface-area–to–volume ratio creates a central area of hemoglobin surrounded by a pale ring and then an outer ring of hemoglobin.

Most Accurate Diagnostic Test

The most accurate diagnostic test when evaluating conditions associated with target cells is:

Hemoglobin Electrophoresis

This test helps identify hemoglobinopathies such as:

• Sickle cell disease
• Hemoglobin C disease
• Thalassemia

Electrophoresis will distinguish between different abnormal hemoglobins and determine specific genetic variants.

Associated Diseases

Target cells may appear in several hematologic and systemic conditions, including:

• Hemoglobinopathies
  • Hemoglobin C disease (most strongly associated)
  • Sickle cell disease (HbSS)
  • Thalassemias (α and β)


• Liver disease
  Due to increased membrane lipids, resulting in excess surface area.
• Iron deficiency anemia
  Though less classic, target cells may be seen in severe cases.

Their presence should prompt consideration of hemoglobin abnormalities or liver dysfunction.


Do Target Cells Have a Shorter Survival?

Despite their abnormal morphology, target cells do NOT have a shorter survival than normal red blood cells.
They are structurally abnormal but not inherently more fragile, unlike spherocytes or sickled cells.

Diagnostic Tests: Sickled Cells

Overview — What This Is


The image shows sickled red blood cells, which are elongated, crescent-shaped RBCs formed due to polymerization of abnormal hemoglobin (HbS). Sickled cells are rigid, fragile, and prone to causing vaso-occlusion and hemolysis.

Diseases Associated With Sickled Cells

Sickled cells are seen only in:

Sickle Cell Disease (HbSS — Homozygous)

• Patients with homozygous hemoglobin S (SS) produce sickled cells, especially during episodes of dehydration, acidosis, hypoxia, or infection.
• These patients exhibit hemolytic anemia, vaso-occlusive crises, acute chest syndrome, splenic infarction, priapism, and other complications.

Important distinction:

• Sickle Cell Trait (AS — Heterozygous) does not produce sickled cells on a routine peripheral smear.
  Individuals are generally hematologically normal, though they may sickle under extreme conditions (e.g., severe hypoxia).

​

Most Accurate Diagnostic Test


The most accurate test for diagnosing sickle cell disease is:


Hemoglobin Electrophoresis


This test identifies and quantifies hemoglobin variants and will show:

• HbS predominates in sickle cell disease (SS)
• A mixture of HbA and HbS in sickle cell trait (AS)

Electrophoresis provides definitive confirmation and distinguishes SS from AS and other hemoglobinopathies.

Diagnostic Tests: Spherocytes on Peripheral Smear

Overview — What These Are

The peripheral smear shows spherocytes, which are small, dense red blood cells lacking the normal central pallor. Their spherical shape results from loss of membrane surface area, making them less deformable and more prone to destruction, especially in the spleen. Spherocytes are a hallmark of hereditary spherocytosis, but can also appear in immune hemolysis.


Most Accurate Diagnostic Test

The most accurate diagnostic test for hereditary spherocytosis is the osmotic fragility test.
This test demonstrates that spherocytes lyse more easily than normal RBCs when placed in hypotonic solutions due to their decreased membrane surface area.


(Note: An elevated MCHC is supportive but not the most accurate test.)


Genetic Defect

Hereditary spherocytosis is caused by defects in red blood cell membrane proteins, most commonly involving:

• Ankyrin gene mutation → leading to
• Spectrin deficiency → which
• Produces membrane instability and premature RBC destruction (extravascular hemolysis)

Other possible but less common defects include band 3 and protein 4.2, but ankyrin/spectrin is the classic board answer.


When to Choose This Diagnosis/Test

You should think of hereditary spherocytosis—and choose osmotic fragility as the test—when the case involves:

• Recurrent hemolysis
• Splenomegaly (often marked)
• Family history of anemia (autosomal dominant pattern in most cases)
• Increased MCHC on CBC (a high-yield clue)
• Spherocytes on peripheral smear
• Signs of hemolysis: jaundice, increased reticulocytes, gallstones (bilirubin stones)

These findings together strongly support hereditary spherocytosis as the diagnosis.

Diagnostic Tests: Rouleaux Formations

Overview — What These Are

The structures shown are rouleaux formations, in which red blood cells stack together like coins. This stacking occurs when plasma proteins reduce the normal negative charge (zeta potential) between RBCs, allowing them to adhere to one another. Rouleaux formation is a nonspecific finding but often reflects elevated levels of certain plasma proteins.


Diseases Associated With Rouleaux Formation

Rouleaux commonly develops in conditions with increased abnormal globulins or elevated fibrinogen, including:


1. Multiple Myeloma

• Overproduction of monoclonal immunoglobulins (especially IgG) promotes RBC stacking.
• Supporting clues include:
  • Anemia
  • Hypercalcemia
  • Renal failure
  • Lytic bone lesions
  • Abnormal SPEP (serum protein electrophoresis) or UPEP (urine protein electrophoresis) showing M-spik
    
    
  
  

2. Waldenström Macroglobulinemia

• Characterized by high levels of IgM macroglobulin, which greatly increases blood viscosity.
• Also causes rouleaux due to elevated globulin levels.

Other possible but less specific associations

• Chronic inflammation
• Connective tissue disorders
• Certain infections
• Conditions with elevated fibrinogen (e.g., acute phase reactions)

But on board-style exams, multiple myeloma and macroglobulinemia are the classic associations.
​